Leslie Citrome, MD, MPH

New York Medical College, Valhalla, New York

More about Dr Citrome Linked in profile need to rework or get permission?

Dr. Citrome is Clinical Professor of Psychiatry and Behavioral Sciences at New York Medical College in Valhalla, New York. He is Editor in Chief of Current Medical Research and Opinion, published by Taylor & Francis. He is the Immediate Past President of the American Society of Clinical Psychopharmacology. Dr. Citrome was the founding Director of the Clinical Research and Evaluation Facility at the Nathan S. Kline Institute for Psychiatric Research in Orangeburg, New York, and after nearly two decades of government service as a researcher in the psychopharmacological treatment of severe mental disorders, Dr. Citrome is now engaged as a consultant in clinical trial design and interpretation. Main areas of interest include schizophrenia, bipolar disorder and major depressive disorder. He is a frequent lecturer on the quantitative assessment of clinical trial results using the evidence-based medicine metrics of number needed to treat and number needed to harm. Dr. Citrome is the author or co-author of over 600 research reports, reviews, and book chapters in the scientific literature, is on the editorial board of 11 different medical journals, Editor Emeritus at the International Journal of Clinical Practice and where he served as Editor in Chief from 2013 through 2019, reviews for over 75 other journals, and has lectured extensively throughout the USA, Canada, Europe, and Asia.

Read articles from ASCP Corner edited by Leslie Citrome

ASCP Corner

 

Articles by Leslie Citrome

JCP
JCP
PCC
Panic Attacks Masquerading as Intractable Vomiting
JCP
Olanzapine and Mirtazapine for Cancer-Related Anorexia
JCP
Economic Impact of Cognitive Impairment and Negative Symptoms in Schizophrenia
JCP
Functional Unblinding in Pivotal Studies and the Future of Psychedelic Medicine
PCC
Smartphone Applications: Therapy at Your Fingertips
JCP
Adjunctive Treatment Targeting Multiple Mechanisms in Schizophrenia
PCC
Zeroing in on Xylazine
PCC
Delusional Disorder and PMDD With Antipsychotic-Induced Hyperprolactinemia
JCP
Prevalence and Course of Unwanted, Intrusive Thoughts of Infant-Related Harm
JCP
Differentiation Across Bipolar Disorder and MDD by Whole-Night Polysomnographic Findings
JCP
Safety and Tolerability of Initiating With Aripiprazole Lauroxil NanoCrystal Dispersion in 1 Day Followed by Aripiprazole Lauroxil Every 2 Months
PCC
Alternative Treatment for Agitation in Schizophrenia and Bipolar Disorder
JCP
Lemborexant and Daridorexant in Insomnia: NNT, NNH, and LHH
JCP
Safety and Efficacy of Aripiprazole 2-Month Ready-to-Use 960 mg
JCP
Non-Dopaminergic Mechanisms for Schizophrenia Symptom Management
JCP
NNT, NNH, and LHH for Lumateperone
JCP
Effect of Zuranolone on Anxiety and Insomnia in Postpartum Depression
JCP
Impact-TD Scale: A Clinical Tool to Assess the Impact of Tardive Dyskinesia
JCP
Sublingual Dexmedetomidine for Agitation in Schizophrenia
JCP
Transdermal HP-3070 for Hostility in Schizophrenia
JCP
JCP